申请人:Shepard Michael H.
公开号:US20070213307A1
公开(公告)日:2007-09-13
This invention provides methods for treating inflammatory or autoimmune diseases by contacting the affected cell or tissue with a therapeutic compound as described herein. Such pathologies include, but are not limited to rheumatoid arthritis, systemic lupus erythmatosus, psoriatic arthritis, reactive arthritis, Crohn's disease, ulcerative colitis and scleroderma. Therapeutic compounds useful in the methods of this invention are selected from the group consisting of a 1,5-substituted pyrimidine derivative or analog and substituted furano-pyrimidone analog.
本发明提供了一种通过将受影响的细胞或组织与本文所述的治疗化合物接触来治疗炎症或自身免疫性疾病的方法。此类病理包括但不限于类风湿性关节炎、系统性红斑狼疮、银屑病性关节炎、反应性关节炎、克罗恩病、溃疡性结肠炎和硬皮病。本发明方法中有用的治疗化合物选自1,5-取代嘧啶衍生物或类似物和取代呋喃嘧啶酮类似物。